Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_assertion type Assertion NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_head.
- NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_assertion description "[The results also demonstrate that cells modified to contain the herpes simplex virus-thymidine kinase (HSV-tk) gene under control of the EGR-1 promoter become sensitive to treatment with the antiviral agent ganciclovir (GCV), whereas nonirradiated cells and nontransfected cells were unaffected by this agent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_provenance.
- NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_assertion evidence source_evidence_literature NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_provenance.
- NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_assertion SIO_000772 8664375 NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_provenance.
- NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_assertion wasDerivedFrom befree-2016 NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_provenance.
- NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_assertion wasGeneratedBy ECO_0000203 NP1351851.RAKWlydhLXo8A1c0S0F2TbeWLv3l5hLkVhpCDM2LsEXlE130_provenance.